The Cancer Molecular Therapeutics Research Association Board of Directors is pleased to announce the location of the
2025 CMTRA conference at
The Homestead Resort in Midway, Utah
The conference is scheduled for July 13-17, 2025.
The CMTRA would love to see you there! Registration will open in early 2025.
​
ABOUT THE CANCER MOLECULAR THERAPEUTICS RESEARCH ASSOCIATION
Our Commitment:
To provide a dynamic platform for the most contemporary and controversial approaches to the treatment of cancer.
​
Each presentation includes a dedicated 50% of the formal presentation time to questions and answers to promote rigorous discussion.
​
To encourage active dialogue amongst investigators from industry, academia, government and foundations.
​
To enable informal and intimate (100 participants) networking for graduate students, postdoctoral fellows, residents and, early-stage and established investigators.
​
To provide the opportunity for the top four poster presenters with the opportunity to orally present their research and attend next year’s conference free of charge.
​
Our meetings build on the legacy of more than two decades of annual conferences.
CMTRA Conferences are remarkable events.
The CMTRA Board and event team anticipate the 2025 Annual Conference at the Homestead Resort and Conference Center in Midway, Utah will live up to all expectations.
See below for pictures from previous CMTRA Annual Conferences.
ANNUAL MEETINGS
Programs
The Cancer Molecular Therapeutics Research Association [CMTRA] was created in 2008 to organize and host the annual Molecular Therapeutics of Cancer meeting. The meeting objective is to provide a forum for presentation and discussion of contemporary research in the field of cancer drug development and therapy. Modeled after small Gordon-type conferences, the meeting provides an opportunity for young and established researchers to discuss and challenge current paradigms for cancer drug development and therapy, as well as a venue where novel ideas can be presented with anticipation of lively debate.
2021-2020 Conference
Cancelled due to the COVID-19 Pandemic
2023 Conference
Watkins Glen Harbor Hotel
Watkins Glen, NY
2019 Conference
Granlibakken Tahoe Resort & Conference Center
Lake Tahoe, CA
2022 Conference
Skamania Lodge
Stevenson, WA
2018 Conference
Sundance Resort
Sundance, UT
2024 Conference
Granlibakken Tahoe Resort & Conference Center
Lake Tahoe, CA
2017 Conference
Hilton Burlington Hotel
Burlington, VT
2014 Conference
Asilomar
Pacific Grove, CA
2016 Conference
University of Washington
Seattle, WA
2013 Conference
University of Colorado
Boulder, CO
2015 Conference
Tufts University
Medford, MA
2012 Conference
Princeton University
Princeton, NJ
CMTRA
Officers & Board Members
MARTIN MCMAHON, PhD
Board President
Cumming-Presidential Professor of Cancer Biology & Senior Director for Preclinical Translation | Huntsman Cancer Institute & Dept. of Dermatology | University of Utah | Salt Lake City, UT
LORI FRIEDMAN, PhD
Board Vice President
Chief Scientific Officer | ORIC Pharmaceuticals |
South San Francisco, CA
WILLIAM J. PLACZEK, PhD
Board Member
Associate Professor | Department of Biochemistry and Molecular Genetics; Director | Central Alabama High-Field NMR Facility; Co-Director | Structural Biology Shared Facility, Cancer Center | The University of Alabama at Birmingham
SHIVA MALEK, PhD
Board Member
Global Head, Oncology | Novartis Institute of Biomedical Research
ARIA VAISHNAVI, PhD
Treasurer
Assistant Professor | Department of Cancer Biology |University of Texas MD Anderson Cancer Center | Houston, TX
EMMA LEES, PhD
Board Member
Senior Vice President, Mechanisms of Cancer Resistance Thematic Research Center | Bristol Myers Squibb
ELI M. WALLACE, PhD
Board Member
Chief Executive Officer, BridgeBio Oncology Therapeutics
BOB ABRAHAM, PhD
Board Member
Scientific Advisor Google Ventures/Distinguished Scientific Fellow | Delphia Therapeutics
ZAHID H. SIDDIK, PhD
Board Member
Professor of Medicine | Pharmacology Department of Experimental Therapeutics | MD Anderson Cancer Center | Houston, TX
MICHELLE ARKIN, PhD
Board Member
Chair and Thomas William and Frederick John MacWilliam Distinguished Professor | Department of Pharmaceutical Chemistry | UCSF | San Francisco, CA
MARCIA HAIGIS, PhD
Board Member
Professor, Department of Cell Biology | Harvard Medical School | Member of the Paul F. Glenn Center for the Biology of Aging
| The Ludwig Center at Harvard Medical School | Boston, MA
Emeritus Board Members:
-
James D. Winkler, Ph.D. - Cheif Scientific Officer | OnKure Therapeutics | Boulder, Colorado
Mary-Ann Bjornsti, Ph.D. - Professor Department of Pharmacology & Toxicology | University of Alabama at Birmingham | Birmingham, AL -
Peter Houghton, Ph.D. - Greehey Children's Cancer Research Institute | UT Health at San Antonio | San Antonio, TX
-
Phillip Dennis, M.D., Ph.D. - Sanofi Oncology |
-
Robert Kramer, Ph.D. - RAKramer Consulting LLC | Newton, PA
-
Alan Eastman, Ph.D. - Professor Emeritus | Norris Cotton Cancer Center | Dartmouth College | Hanover, NH
-
John A. Hickman, D.Sc. - Agon Consulting, Paris
-
Branimir I. Sikic, M.D. - Director | Stanford Clinical & Translational Research Unit; Co-director | Stanford University School of Medicine | Stanford, CA
